Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Business

>> PFIZER Latest News

APR 17, 2015 - St. Louis Post-Dispatch

A Must Read - Share

Jury rules in favor of Pfizer in first Zoloft-birth defect case to go to trial

But more lawsuits are to come alleging that the antidepressant Zoloft caused birth defects when taken during pregnancy. 

Tags: Jury rules in favor of Pfizer in first Zoloft-birth defect case to go to trial,  Pfizer Latest News

APR 17, 2015 - TheStreet

A Must Read - Share

Netflix (NFLX) Stock Higher Today Following Positive Analyst Note

NEW YORK (TheStreet) -- Shares of Netflix  are higher by 1.06% to $568.03 on heavy volume in afternoon trading Friday, following a positive note by analysts at BTIG Research released yesterday. The firm said that the average Netflix user streams movies and programs for two hours a day, up about 18 minutes per subscriber per day compared to BTIG's prior estimates, ...

Tags: Netflix (NFLX) Stock Higher Today Following Positive Analyst Note,  Pfizer Latest News

APR 17, 2015 - Zacks Investment Research

A Must Read - Share

Pfizer's Ibrance Study Stopped Early on Favorable Data - Analyst Blog

Pfizer announced that based on an assessment by an independent Data Monitoring Committee, a phase III study on Ibrance was stopped early as the study met its primary endpoint.

Tags: Pfizer's Ibrance Study Stopped Early on Favorable Data - Analyst Blog,  Pfizer Latest News

APR 17, 2015 - TheStreet

A Must Read - Share

Antitrust Protections Hardly Provide a 'Road Map' for Merger Challenges, Regulators Say

NEW YORK (TheDeal) -- Merging parties, particularly target companies, frequently insist on merger-agreement covenants aimed at ensuring that the other side of a deal will remain committed to the transaction in the face of intervention from antitrust authorities. Those provisions include reverse breakup fees entitling the target to some percentage of the deal's value if the transaction fails to win regulatory approval, ...

Tags: Antitrust Protections Hardly Provide a 'Road Map' for Merger Challenges, Regulators Say,  Pfizer Latest News

APR 17, 2015 - TheStreet

A Must Read - Share

Biotech Stock Mailbag: Bluebird's Sickle Cell Data, Ariad's Faux Suitors, XBiotech Blech

BOSTON (TheStreet) -- In this week's Biotech Stock Mailbag, Ron D. emails, "Do you expect Bluebird Bio to have the same positive results in sickle cell disease that they had with beta-thalassemia? When will the company tell us about its sickle cell patients and is there a way for ordinary investors to figure out what is good or not?" I ...

Tags: Biotech Stock Mailbag: Bluebird's Sickle Cell Data, Ariad's Faux Suitors, XBiotech Blech,  Pfizer Latest News